摘要
体外诊断试剂集中采购是我国医改领域战略购买和医药集采治理的重要内容,当前各类采购工作模式优劣并存、亟待完善。本文在分析我国开展体外诊断(IVD)试剂集中带量采购工作必要性与迫切性的基础上,对院级自主非集中采购、地市级集中招标采购、省级集中挂网采购和省级集中带量采购等四种当前主要采购工作模式进行了介绍和比较分析,并提出政策建议。
Abstract
The centralized procurement of in-vitro diagnostic reagents is an important part of the strategic purchase and centralized medical procurement management in the field of medical reform in China. At present, various procurement work modes have both advantages and disadvantages and need to be improved. This paper introduces, compares and analyzes four current main procurement work modes, including hospital-level independent non-centralized procurement, prefectural-level centralized bidding procurement, provincial-level centralized online procurement, and provincial-level centralized procurement with volume, and puts forward policy suggestions.
关键词
体外诊断试剂 /
集中采购 /
模式 /
建议
Key words
in-vitro diagnostic reagents /
centralized procurement /
mode /
suggestion
胡宏伟, 王爽.
关于我国体外诊断试剂集采的几点思考[J]. 中国医疗保险. 2022, 0(6): 48-53 https://doi.org/10.19546/j.issn.1674-3830.2022.6.010
Thoughts on Centralized Procurement of In-Vitro Diagnostic Reagents in China[J]. China Health Insurance. 2022, 0(6): 48-53 https://doi.org/10.19546/j.issn.1674-3830.2022.6.010
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 国务院办公厅.国家食品药品监督管理总局令(第5号)体外诊断试剂注册管理办法[EB/OL].(2014-07-30)[2022-05-13]. http://www.gov.cn/gongbao/content/2014/content_2758501.htm.
[2] IVD行业深度研究系列报告(一)[R].IVD行业深度研究系列报告(一)[R].上海:中银证券,2021.
[3] 中国医疗器械上市公司发展白皮书——体外诊断篇[R].中国医疗器械上市公司发展白皮书——体外诊断篇[R].上海:华夏基石,2019.
[4] 张煜唯. 集中采购下体外诊断试剂价格畸高与竞争政策[D].大连:东北财经大学,2019.
[5] 花陈祥. 体外诊断试剂价格决策研究——以RDSH公司为例[D].上海:华东理工大学,2016.
[6] 曹群,陈富强,方沅湘等.大型医院临床应用体外诊断试剂采购管理策略研究[J].中国医院. 2018(03):66-68.
[7] 陈燕,佘艳.体外诊断试剂公开招标实践与分析[J].中国招标,2019(03):44-46.